
Overview
Associate, Admitted only in Utah. Supervised by D.C. Bar member Matthew Bodenstein
Mark Arrington, Ph.D., is an associate in Sterne Kessler’s Biotechnology & Chemical Practice Group. He assists in patent preparation and prosecution in the biotechnology, chemical, and pharmaceutical industries. Mark also regularly advises clients on freedom to operate, patentability, and validity of patents in the chemical space. Mark’s technical areas of expertise include synthetic organic and medicinal chemistry, small molecule and oligonucleotide pharmaceuticals, and agricultural chemistry.
Prior to joining Sterne Kessler, Mark was in-house IP counsel at a San Diego biotech company and an associate with a Salt Lake City-based IP boutique law firm.
Before becoming an attorney, Mark was a medicinal chemist in the pharmaceutical industry where he developed therapeutics directed to neuroscience, metabolic, and cancer indications.
Mark earned his J.D. from the S.J. Quinney College of Law at the University of Utah. He earned his Ph.D. in synthetic organic chemistry from Colorado State University and did post-doctoral research at The Ohio State University. Mark earned his B.S. from UC San Diego.
Technical Publications
- Coauthor, “Cetirizine and Loratadine-based Antihistamines with 5-Lipoxygenase Inhibitory Activity.” (2004) Bioorg. Med. Chem. Lett, 14, 22, 5591-5594.
- Coauthor, “Constraining of Small-Ring Cyclic Ether Triads by Stereodefined Spiroannulation to an Inositol Orthoformate Platform. Solution- and Gas-Phase Alkali Metal Binding Affinities for Three- to Five-Membered Ring Structural Combinations.” (2001) J. Org. Chem. 66, 25, 8629–8639.
- Coauthor, “Enantioselective Double Michael Addition/Cyclization with an Oxygen-Centered Nucleophile as the First Step in a Concise Synthesis of Natural (+)-Asteriscanolide.” (2000) J. Am. Chem. Soc. 122, 12, 2742–2748.
- Arrington, et. al., “Asymmetric Synthesis of the Core Cyclopentane of Viridenomycin.” (1999) Chem. Comm. 1371.
- Arrington, et. al., “Modified Cinchona Alkaloid Ligands: Improved Selectivities in the Osmium Tetroxide Catalyzed Asymmetric Dihydroxylation (AD) of Terminal Olefins.” Tet. Lett. (1993) 34, 36, 7375-7378.
Education
- J.D., S.J. Quinney College of Law
- Ph.D., Colorado State University
- B.S., University of California, San Diego